|
Berg, K A; Stout, B D; Cropper, J D et al. (1999) Novel actions of inverse agonists on 5-HT2C receptor systems. Mol Pharmacol 55:863-72
|
|
Berg, K A; Maayani, S; Goldfarb, J et al. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104
|
|
Berg, K A; Maayani, S; Clarke, W P (1996) 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50:1017-23
|
|
Clarke, W P; Yocca, F D; Maayani, S (1996) Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. J Pharmacol Exp Ther 277:1259-66
|
|
Berg, K A; Maayani, S; McKay, R et al. (1995) Nerve growth factor amplifies cyclic AMP production in the HT4 neuronal cell line. J Neurochem 64:220-8
|
|
Berg, K A; Clarke, W P; Chen, Y et al. (1994) 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. Mol Pharmacol 45:826-36
|
|
Berg, K A; Clarke, W P; Sailstad, C et al. (1994) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol Pharmacol 46:477-84
|
